Abstract:Background. Microarray technology enables a standardized, objective assessment of oncological diagnosis and prognosis. However, such studies are typically specific to certain cancer types, and the results have limited use due to inadequate validation in large patient cohorts. Discovery of genes commonly regulated in cancer may have an important implication in understanding the common molecular mechanism of cancer. Methods and Findings. We described an integrated gene-expression analysis of 2,186 samples from 39 studies to identify and validate a cancer type-independent gene signature that can identify cancer patients for a wide variety of human malignancies. The commonness of gene expression in 20 types of common cancer was assessed in 20 training datasets. The discriminative power of a signature defined by these common cancer genes was evaluated in the other 19 independent datasets including novel cancer types. QRT-PCR and tissue microarray were used to validate commonly regulated genes in multiple cancer types. We identified 187 genes dysregulated in nearly all cancerous tissue samples. The 187-gene signature can robustly predict cancer versus normal status for a wide variety of human malignancies with an overall accuracy of 92.6%. We further refined our signature to 28 genes confirmed by QRT-PCR. The refined signature still achieved 80% accuracy of classifying samples from mixed cancer types. This signature performs well in the prediction of novel cancer types that were not represented in training datasets. We also identified three biological pathways including glycolysis, cell cycle checkpoint II and plk3 pathways in which most genes are systematically up-regulated in many types of cancer. Conclusions. The identified signature has captured essential transcriptional features of neoplastic transformation and progression in general. These findings will help to elucidate the common molecular mechanism of cancer, and provide new insights into cancer diagnostics, prognostics and therapy.

The minimal number of genes needed to identify a tumor

Feature (gene) Selection in Gene Expression-Based Tumor Classification

Perfect genetic biomarkers for cancer from a fresh view of gene dysregulation

Algorithm for Finding Optimal Gene Sets in Microarray Prediction

Comment on `Quantum-Anti-Zeno Paradox'

Transcriptome Complexity Disentangled: A Regulatory Molecules Approach

Common Human Cancer Genes Discovered by Integrated Gene-Expression Analysis

Identification of Key Genes with Differential Correlations in Lung Adenocarcinoma

TaqMan Low Density Array is Roughly Right for Gene Expression Quantification in Colorectal Cancer.

Estimating the number of available states for normal and tumor tissues in gene expression space

Dynamics of N-genes and T-genes in cancer

Identification of deregulated transcription factors involved in subtypes of cancers

Are Thousands of Samples Really Needed to Generate Robust Gene-List for Prediction of Cancer Outcome?

A Comparative Analysis of Gene Expression Profiling by Statistical and Machine Learning Approaches

Inferring genetic networks: An information theoretic approach

Identification of gene signatures used to recognize biological characteristics of gastric cancer upon gene expression data.

PLS-based gene subset augmentation and tumor-specific gene identification

Identifying Gene Regulatory Networks from Experimental Data

A sparse regulatory network of copy-number driven expression reveals putative breast cancer oncogenes

A Global View of Regulatory Networks in Lung Cancer: an approach to understand homogeneity and heterogeneity.

Cancer Gene Profiling through Unsupervised Discovery